title: Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.
abstract: Prostate cancer shows evidence of familial aggregation, particularly at young ages at diagnosis, but the inherited basis of familial prostate cancer is poorly understood. Smith et al. recently found evidence of linkage to markers on 1q, at a locus designated "HPC1," in 91 families with multiple cases of early-onset prostate cancer. Using both parametric and nonparametric methods, we attempted to confirm this finding, in 60 affected related pairs and in 76 families with three or more cases of prostate cancer, but we found no significant evidence of linkage. The estimated proportion of linked families, under a standard autosomal dominant model, was 4%, with an upper 95% confidence limit of 31%. We conclude that the HPC1 locus is responsible for only a minority of familial prostate cancer cases and that it is likely to be most important in families with at least four cases of the disease.
authors.affiliation: Cancer Genetics Team, ICR and Royal Marsden NHS Trust, Sutton, Surrey SM2 5PT, United Kingdom. ros@icr.ac.uk
authors.forename: R A
authors.initials: RA
authors.lastname: Eeles
authors.forename: F
authors.initials: F
authors.lastname: Durocher
authors.forename: S
authors.initials: S
authors.lastname: Edwards
authors.forename: D
authors.initials: D
authors.lastname: Teare
authors.forename: M
authors.initials: M
authors.lastname: Badzioch
authors.forename: R
authors.initials: R
authors.lastname: Hamoudi
authors.forename: S
authors.initials: S
authors.lastname: Gill
authors.forename: P
authors.initials: P
authors.lastname: Biggs
authors.forename: D
authors.initials: D
authors.lastname: Dearnaley
authors.forename: A
authors.initials: A
authors.lastname: Ardern-Jones
authors.forename: A
authors.initials: A
authors.lastname: Dowe
authors.forename: R
authors.initials: R
authors.lastname: Shearer
authors.forename: D L
authors.initials: DL
authors.lastname: McLellan
authors.forename: D L
authors.initials: DL
authors.lastname: McLennan
authors.forename: R L
authors.initials: RL
authors.lastname: Norman
authors.forename: P
authors.initials: P
authors.lastname: Ghadirian
authors.forename: A
authors.initials: A
authors.lastname: Aprikian
authors.forename: D
authors.initials: D
authors.lastname: Ford
authors.forename: C
authors.initials: C
authors.lastname: Amos
authors.forename: T M
authors.initials: TM
authors.lastname: King
authors.forename: F
authors.initials: F
authors.lastname: Labrie
authors.forename: J
authors.initials: J
authors.lastname: Simard
authors.forename: S A
authors.initials: SA
authors.lastname: Narod
authors.forename: D
authors.initials: D
authors.lastname: Easton
authors.forename: W D
authors.initials: WD
authors.lastname: Foulkes
mesh_terms: D002878:Chromosomes, Human, Pair 1; D018740:Genetic Heterogeneity; D008040:Genetic Linkage; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D008126:Lod Score; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics*
chemical_list: D005819:Genetic Markers